Skip to main content

Table 2 The clinical features and genes expressed in the CIN and normal groups

From: Establishment of multifactor predictive models for the occurrence and progression of cervical intraepithelial neoplasia

  normal CIN Z/X2 P
age 44.08 ± 10.00 41.71 ± 9.31 −1.480 0.139
gravidity 3.00 ± 1.76 3.46 ± 1.84 −1.536 0.124
parity 1.66 ± 0.85 1.67 ± 1.34 −0.561 0.561
HPV infection    26.552 0.000
 positive 15 47   
 negative 23 5   
menopause
 yes 9 9 0.558 0.455
 no 29 43   
TCT
 CINII-(Normal/ASCUS) 28 10 / 0.000
 CINII+(LSIL/HSIL/SCC) 16 36   
 CTNNB1 0.85 ± 0.15 0.88 ± 0.24 −1.626 0.104
TGFBR2 1613.35 ± 369.73 665.56 ± 357.49 −2.916 0.004
FOXO1 0.04 ± 0.01 0.50 ± 0.30 −2.728 0.006
PRKCI 0.65 ± 0.22 0.56 ± 0.11 −1.675 0.094
CSKN1A1 211.45 ± 120.00 135.69 ± 81.39 −0.270 0.787
TP73 150.80 ± 44.11 75.39 ± 21.31 −1.805 0.071
MUC2 0.92 ± 0.25 1.89 ± 1.26 −0.343 0.732
PIK3CA 4.91 ± 0.87 7.28 ± 1.98 −1.005 0.315
CCND2 0.47 ± 0.19 1.40 ± 0.72 −0.556 0.579
CTPB2 40.18 ± 11.28 16.59 ± 6.14 −2.091 0.037